A Single-Center, Phase 2 Study Evaluating Bilastine Ophthalmic Solution in the CAC® Model
Clinical trial NCT03231969 · COMPLETED
Trial details
- NCT number
- NCT03231969
- Sponsor
- Faes Farma, S.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-20
- Primary completion
- 2017-10-11
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.